RLX Technology Inc. American Depositary Shares (RLX)
1.9400
-0.0600 (-3.00%)
NYSE· Last Trade: Aug 14th, 4:19 PM EDT
Detailed Quote
| Previous Close | 2.000 |
|---|---|
| Open | 1.850 |
| Bid | 1.900 |
| Ask | 2.000 |
| Day's Range | 1.810 - 1.970 |
| 52 Week Range | 1.760 - 2.840 |
| Volume | 8,777,412 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | 0.0100 (0.52%) |
| 1 Month Average Volume | 1,657,152 |
Chart
About RLX Technology Inc. American Depositary Shares (RLX)
Rlx Technology Inc is a leading company in the production and distribution of innovative vaping products and smokeless electronic devices, catering primarily to the Chinese market. The company focuses on creating high-quality, user-friendly vaping solutions designed to enhance the consumer experience while promoting a smoke-free lifestyle. With a strong commitment to research and development, Rlx Technology aims to offer a diverse range of products that meet evolving consumer preferences and regulatory standards, positioning itself as a key player in the growing nicotine alternatives market. Read More
News & Press Releases
RLX Technology (NYSE:RLX) reported second-quarter financial results on Friday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
Via Benzinga · August 14, 2026
RLX Technology (NYSE:RLX) reported second-quarter 2026 revenue growth of 14.8% year over year, supported primarily by international expansion, while management outlined plans to deepen its European distribution footprint and broaden its portfolio of smoke-free products.
Net revenue for the quarter
Via MarketBeat · August 14, 2026
RLX (RLX) Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 20, 2026
RLX Technology (NYSE:RLX) Soars 3.8% Pre-Market on Massive Q1 2026 Revenue Beat, Topping Estimates by 34%chartmill.com
Via Chartmill · May 20, 2026
RLX (RLX) Q4 2025 Earnings Call Transcript
Via The Motley Fool · May 20, 2026
RLX Technology (NYSE:RLX) reported a sharp increase in first-quarter 2026 revenue, driven by international expansion, contributions from a European investment and continued stability in mainland China, executives said on the company’s earnings call.
Chief Executive Officer Kate Wang said the compan
Via MarketBeat · May 20, 2026
Legend Biotech develops cell therapies for cancer, with a pipeline spanning hematologic malignancies and solid tumors.
Via The Motley Fool · May 17, 2026
Full Truck Alliance is a top digital freight platform in China, connecting shippers and truckers through tech-enabled logistics services.
Via The Motley Fool · May 17, 2026
A sharply concentrated fund leaned further into New Oriental even as sentiment cooled.
Via The Motley Fool · January 1, 2026
A contrarian allocation into China’s largest housing platform highlights where disciplined capital is looking for durability, cash flow, and optionality in an out-of-favor market.
Via The Motley Fool · December 28, 2025
A full exit after a monster rally says less about the company’s science and more about how disciplined funds lock in wins when portfolio math starts to matter.
Via The Motley Fool · December 26, 2025
A patient, partnership-driven family office didn’t wait for fundamentals to break before walking away, and that timing may matter more than the sale itself.
Via The Motley Fool · December 26, 2025
Via Benzinga · November 14, 2025
RLX Technology (RLX) Q3 2025 Earnings Transcript
Via The Motley Fool · November 14, 2025
Via Benzinga · November 14, 2025
Via Benzinga · September 8, 2025
Via Benzinga · September 2, 2025
RLX Technology Q2 2025 results: Revenue of $881.9M beats estimates, but EPS of $0.144 falls short, indicating mixed performance.
Via Chartmill · August 22, 2025
RLX Technology (NYSE:RLX) fits Mark Minervini’s Trend Template with strong technicals, high relative strength, and accelerating revenue & earnings growth, making it a high-growth momentum candidate.
Via Chartmill · August 1, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 9, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 5, 2025
